Treatment Abroad – Find Verified Clinics, Reviews & Prices

Herniated Discs

A liver hemangioma is a benign (noncancerous) growth in the liver formed by a cluster of blood vessels. It is also known as a hepatic hemangioma or cavernous hemangioma. Most liver hemangiomas are discovered incidentally during imaging tests performed for other reasons. They are very common—affecting up to 20% of people—and usually cause no symptoms. In the vast majority of cases, no treatment is required. Although finding a mass in the liver can be concerning, liver hemangiomas are not cancerous and do not turn into liver cancer. There is no evidence that leaving a liver hemangioma untreated increases cancer risk. In simple terms, a liver hemangioma is a harmless collection of blood vessels within the liver that typically does not affect health or liver function.

Chronic myeloid leukemia (CML) is a rare type of blood cancer that develops in the bone marrow when immature white blood cells, called myeloid cells, begin to grow and multiply at an abnormal rate. These abnormal cells crowd out healthy blood cells, leading to anemia, infection risk and bleeding problems. CML is strongly linked to a specific genetic change known as the Philadelphia chromosome, which leads to the production of an abnormal protein that drives uncontrolled cell growth. CML most commonly affects adults and is rare in children, accounting for about 3% of childhood leukemia cases. When it does occur in children, careful diagnosis and specialized treatment are essential. CML progresses through three phases: Chronic phase – early stage, usually mild symptoms Accelerated phase – disease becomes more aggressive Blast (acute) phase – behaves like acute leukemia and is life-threatening Pediatric CML Signs and Symptoms CML in children can vary widely. Some children have clear symptoms, while others may be diagnosed during routine blood tests. Common symptoms include: Persistent fatigue and weakness Easy bruising or bleeding, even after minor injuries Bone pain, especially in the legs and long bones Night sweats and chills Unexplained weight loss Abdominal pain or fullness (often due to enlarged spleen) Pale skin caused by anemia Persistent or recurrent fever These symptoms are not specific to CML, so proper medical evaluation is always required. Pediatric CML Diagnosis To confirm CML, doctors use several tests: Blood Tests Complete Blood Count (CBC): High white blood cell count, low red blood cells and platelets Peripheral Blood Smear: Detects immature cells (blasts) and abnormal blood cell shapes Bone Marrow Aspiration and Biopsy Samples of liquid and solid bone marrow are examined to identify leukemia cells and assess disease phase. Flow Cytometry Uses laser technology to analyze leukemia cells in detail, helping confirm the diagnosis. Imaging Tests Used to assess organ involvement: CT scan: Detects enlarged spleen, liver or lymph nodes MRI: Evaluates organs, bones and tissues Ultrasound: Checks spleen, liver, kidneys and sometimes brain involvement Pediatric CML Treatment Options Treatment depends on disease phase, response to therapy and overall health. Targeted Therapy (First-Line Treatment) Uses tyrosine kinase inhibitors (TKIs) Targets the genetic abnormality caused by the Philadelphia chromosome Highly effective and often allows long-term disease control Chemotherapy Used less commonly as a stand-alone treatment May be combined with targeted therapy Often used before a bone marrow transplant Bone Marrow (Stem Cell) Transplant Considered when targeted therapy fails or disease is advanced Replaces diseased marrow with healthy stem cells Offers the only potential cure, but carries higher risks Key Takeaway Although pediatric CML is rare, modern targeted therapies have transformed outcomes, allowing many children to live normal, active lives. Early diagnosis, close monitoring and treatment at specialized centers are critical for the best results.